BMY
Bristol-Myers Squibb Company
Stock
$61.15−0.31 (−0.50%)Close Oct 2, 2026
- Long-term debt, 2025
- $42.9B
- YoY, 2025
- −10.0%
- 5-year CAGR
- −2.4%
- 10-year CAGR
- +20.7%
Long-term debt
Long-term debt by fiscal year
| Period | Long-term debt | YoY |
|---|---|---|
| 2025 | $42.9B | −10.0% |
| 2024 | $47.6B | +29.9% |
| 2023 | $36.7B | +4.6% |
| 2022 | $35.1B | −11.5% |
| 2021 | $39.6B | −18.1% |
| 2020 | $48.3B | +11.4% |
| 2019 | $43.4B | +668.5% |
| 2018 | $5.6B | −19.1% |
| 2017 | $7.0B | +22.0% |
| 2016 | $5.7B | −12.7% |
| 2015 | $6.6B | −9.6% |
| 2014 | $7.2B | −9.3% |
| 2013 | $8.0B | +21.5% |
| 2012 | $6.6B | +22.2% |
| 2011 | $5.4B | +0.9% |
| 2010 | $5.3B | −13.1% |
| 2009 | $6.1B | −6.9% |
| 2008 | $6.6B | — |